Nuvectis Pharma, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Nuvectis Pharma, Inc. (NVCT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 43.50 thousand shares for the 1-month period ending 2023-01-31, per its 10-Q filed 2023-11-08.
Discontinued
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2023-11-08
- 2023-01-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month 43.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1 month |
|---|---|
| 2023-01-31 | 43.50K shares 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |